Isosorbide Mononitrate Tablet Market Report 2026

Isosorbide Mononitrate Tablet Market Overview

• Isosorbide Mononitrate Tablet market size has reached to $1.2 billion in 2025 • Expected to grow to $1.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: The Rising Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Increasing Demand For Effective Heart Disease Management Solutions • Market Trend: The Role Of Extended-Release Tablets In Improving Patient Compliance And Treatment Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Isosorbide Mononitrate Tablet Market?

Isosorbide mononitrate tablet is a long-acting nitrate medication primarily used to prevent and control chest pain (angina) associated with coronary artery disease. It works by relaxing and dilating blood vessels, particularly in the heart, allowing for increased blood and oxygen flow while reducing the heart's workload. Unlike fast-acting nitrates used for immediate relief, isosorbide mononitrate is taken regularly as a maintenance therapy to reduce the frequency and severity of angina attacks and improve overall cardiovascular function. The main dosage forms of isosorbide mononitrate tablets are immediate-release tablets and extended-release tablets. Immediate-release tablets are designed to dissolve quickly, delivering rapid absorption for fast relief, particularly in conditions such as angina. These tablets are used for various indications, such as angina pectoris, heart failure, and hypertension, and are distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Isosorbide Mononitrate Tablet Market Growth Forecast?

The isosorbide mononitrate tablet market size is expected to see strong growth in the next few years. It will grow to $1.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growth in chronic cardiovascular conditions, increasing demand for extended-release tablets, rising adoption of online pharmacies, improved diagnosis of angina and heart failure, expanding access to cardiovascular medicines in emerging markets. Major trends in the forecast period include long-acting cardiovascular maintenance therapies, rising preference for extended-release formulations, growing use of generic nitrate medications, improved patient adherence through once-daily dosing, expansion of online and retail pharmacy access.

Global Isosorbide Mononitrate Tablet Market Segmentation

1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets 2) By Indication Type: Angina Pectoris, Coronary Artery Disease (CAD) 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Immediate-Release Tablets: Low-Dose, Single Strength Tablets 2) By Extended-Release Tablets: Moderate-Dose, High-Dose, Once-Daily Formulation, Twice-Daily Formulation

What Are The Drivers Of The Isosorbide Mononitrate Tablet Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the isosorbide mononitrate tablet market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, and hypertension. The rising prevalence of cardiovascular diseases is primarily attributed to unhealthy diets, which often include high levels of saturated fats, trans fats, sodium, and added sugars, leading to conditions such as obesity, hypertension, and high cholesterol. Isosorbide mononitrate tablets help manage cardiovascular diseases by relaxing and widening blood vessels, which improves blood flow and reduces the heart's workload, thereby alleviating chest pain (angina), lowering blood pressure, and enhancing oxygen delivery to the heart muscle. For instance, in September 2025, according to the Global Burden of Disease study reported by the American College of Cardiology, a US-based nonprofit medical association and professional society for cardiologists, there were 19.2 million cardiovascular disease deaths worldwide in 2023. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the isosorbide mononitrate tablet industry. The rise in online pharmacies is expected to propel the growth of the isosorbide mononitrate tablet market going forward. Online pharmacies refer to digital platforms or websites that allow consumers to purchase prescription and over-the-counter medications over the internet. The rise in online pharmacies is primarily due to increasing consumer demand for convenience, affordability, and accessibility to medications and healthcare products without the need to visit physical stores. Online pharmacies facilitate convenient access to isosorbide mononitrate tablets by offering home delivery, competitive pricing, and improved availability, especially for patients managing chronic conditions. For instance, in May 2024, according to the World Health Organization, a Switzerland-based international public health agency, the number of digital requests for repeat prescriptions made through the national health service (NHS) App increased by more than 45% in 2023, reaching 3.1 million requests per month. Therefore, the rise in online pharmacies is driving the growth of the isosorbide mononitrate tablet industry.

Key Players In The Global Isosorbide Mononitrate Tablet Market

Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co., Inc., AstraZeneca plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Qilu Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd.

Global Isosorbide Mononitrate Tablet Market Trends and Insights

Major companies operating in the isosorbide mononitrate tablet market are focusing on developing innovative products such as extended-release (ER) formulations to enhance patient compliance, provide sustained therapeutic effects, and optimize treatment outcomes for conditions such as angina pectoris. An extended-release formulation is an advanced drug delivery system that allows for the gradual release of medication over an extended period, reducing dosing frequency and maintaining consistent blood levels. For instance, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical manufacturing company, received approval from the United States Food and Drug Administration (USFDA) to manufacture and market isosorbide mononitrate extended-release tablets USP in strengths of 30 mg, 60 mg, and 120 mg. These tablets are used to prevent chest pain (angina) in patients with coronary artery disease and are equivalent to the reference listed drug (RLD), imdur extended-release tablets.

Regional Outlook

North America was the largest region in the isosorbide mononitrate tablet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Isosorbide Mononitrate Tablet Market?

The isosorbide mononitrate tablet market consists of sales of dilatrate-SR, isochron, monoket, and imdur, pediatric and geriatric-adjusted tablets, and combination products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Isosorbide Mononitrate Tablet Market Report 2026?

The isosorbide mononitrate tablet market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the isosorbide mononitrate tablet industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.